Saudi Arabia vs Syria: Treatment for hypertension, female
Saudi Arabia
49.5%
in 2019
Syria
50.8%
in 2019
Saudi Arabia rank
93rd
Syria rank
90th
Treatment for hypertension, female over time
- Saudi Arabia
- Syria
How they compare
Syria currently reports 50.8% against 49.5% in Saudi Arabia, a difference of 1.3%.
Across all 30 years both countries report, Syria has been ahead every year.
Saudi Arabia ranks 93rd and Syria ranks 90th of 192 countries.
Syria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Saudi Arabia | Syria | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 29.5% | 31.1% | 1.6% | Syria |
| 2000s | 39.7% | 41.0% | 1.3% | Syria |
| 2010s | 48.5% | 49.6% | 1.2% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment for hypertension, female, Saudi Arabia or Syria?
- Syria, at 50.8% against 49.5% in Saudi Arabia as of 2019.
- What is the difference in treatment for hypertension, female between Saudi Arabia and Syria?
- 1.3%, with Syria ahead.
- How many years of comparable data are there for Saudi Arabia and Syria?
- 30 years are reported by both, from 1990 to 2019.
- How do Saudi Arabia and Syria rank globally for treatment for hypertension, female?
- Saudi Arabia ranks 93rd and Syria ranks 90th of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, female (% of female adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment for hypertension is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.